CompletedNot Applicable

Total Laparoscopic vs Open Pancreaticoduodenectomy for the Treatment of Periampullary Adenocarcinomas

Egypt40 participantsStarted 2023-08-05

Plain-language summary

Laparoscopic pancreaticoduodenectomy (LPD), a surgical option for nonpancreatic periampullary adenocarcinoma (NPPA), is a complex procedure that has become increasing popular. However, there is no consensus as to whether this technique should be performed routinely. Our aim was to evaluate the outcomes of LPD compared with open pancreaticoduodenectomy (OPD).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Body mass index \<28.0 kg/m2. * Ampullary tumors, duodenal tumors restricted to the second part of the duodenum, or lower common bile duct tumors. * Carefully confirmed resectability of the tumors based on preoperative radiology conducted by experienced radiologists and surgeons. Exclusion Criteria: * • Patients with \>180 degrees superior mesenteric artery encasement * Any celiac abutment. * Unreconstructable superior mesenteric vein/portal occlusion" Aortic invasion or encasement. * A history of previous upper abdominal surgery. * Tumors extending to the uncinate. * Severe cardiorespiratory comorbidities.

What they're measuring

The incidence of pancreatic fistula after laparoscopic pancreaticoduodenectomy in comparison to open surgery

Timeframe: in 2 years between 2023 - 2025

Trial details

NCT IDNCT07388082

SponsorTheodor Bilharz Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-05

View on ClinicalTrials.gov More Periampullary Carcinoma trials